Stocks edged lower on Wall Street in afternoon trading Wednesday, keeping major indexes on track to extend their recent losing streak into a fifth day.
The S&P 500 fell 0.2% as of 2:29 p.m. Eastern. The Dow Jones Industrial Average fell 10 points, or less than 0.1%, to 33,585 and the tech-heavy Nasdaq composite fell 0.5%.
Every major index is on track for weekly losses.
Treasury yields fell significantly. The yield on the 10-year Treasury slid to 3.43% from 3.53% late Tuesday.
Investors have been dealing with a relative lack of news ahead of updates on inflation and consumer sentiment later this week and the Federal Reserve’s meeting next week.
China rolled back more of its strict COVID-19 rules that have hindered that nation’s economy and added more uncertainty to global supply chains.
Markets in Asia closed lower overnight and European markets mostly fell. U.S. crude oil prices fell 3%.
Technology and communication services stocks were the biggest weights on the benchmark S&P 500 index. Apple fell 1.3% and Google parent Alphabet was down 1.9%.
Health care stocks were among the few bright spots. Pfizer rose 1.3%.
Investors rewarded several companies for solid earnings reports. Campbell Soup rose 5.5% after reporting strong results.
Carvana plunged 41.4% after analysts at Wedbush Securities warned that the used vehicle chain’s bankruptcy risk is rising. The company has lost 98% of its value since the beginning of the year.
Inflation, the Fed’s aggressive interest rate increases and recession worries remain the big concerns for Wall Street. Economic updates later this week could give investors more insight into inflation’s path ahead and how the Fed will continue fighting high prices.
The U.S. will release data on weekly unemployment claims on Thursday. The jobs market has been a strong area of the otherwise slowing economy and that has made it more difficult for the Fed to tame inflation.
The government will release a report on wholesale prices Friday that will provide more details on how inflation is affecting businesses. The University of Michigan will release a December survey on consumer sentiment on Friday.
The reports do not typically move markets but are receiving elevated attention as they are some of the final data dumps before the Fed meets next week.
The central bank is expected to raise interest rates by a half-percentage point at its meeting next week. It has raised its benchmark rate six times since March, driving it to a range of 3.75% to 4%, the highest in 15 years. Wall Street expects the benchmark rate to reach a peak range of 5% to 5.25% by the middle of 2023.
Inflation has been easing and economists expect the upcoming data on wholesale and consumer prices to reflect that trend. The pace has been slow, though, and the Fed has been very clear about its intent to keep raising interest rates until it is sure that inflation is cooling. That has raised concerns that the central bank could hit the brakes too hard on the economy and cause a recession.
A growing number of analysts expect the U.S. economy to slip into a recession in 2023, but are unsure of its potential severity and duration.
Elaine Kurtenbach and Matt Ott contributed to this report.
Before you consider Pfizer, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Pfizer wasn’t on the list.
While Pfizer currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here